Literature DB >> 34174363

Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors.

Donald F Chute1, Sophia Zhao1, Ian A Strohbehn1, Nifasha Rusibamayila1, Harish Seethapathy1, Meghan Lee1, Leyre Zubiri2, Shruti Gupta3, David E Leaf3, Osama Rahma4, Zsofia D Drobni5, Tomas G Neilan6, Kerry L Reynolds2, Meghan E Sise7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34174363      PMCID: PMC8855486          DOI: 10.1053/j.ajkd.2021.05.012

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  10 in total

1.  Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney Function.

Authors:  Edward D Siew; Khaled Abdel-Kader; Amy M Perkins; Robert A Greevy; Sharidan K Parr; Jeffrey Horner; Andrew J Vincz; Jason Denton; Otis D Wilson; Adriana M Hung; Cassianne Robinson-Cohen; Michael E Matheny
Journal:  Am J Kidney Dis       Date:  2019-09-16       Impact factor: 8.860

2.  Past Decline Versus Current eGFR and Subsequent ESRD Risk.

Authors:  Csaba P Kovesdy; Josef Coresh; Shoshana H Ballew; Mark Woodward; Adeera Levin; David M J Naimark; Joseph Nally; Dietrich Rothenbacher; Benedicte Stengel; Kunitoshi Iseki; Kunihiro Matsushita; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2015-12-11       Impact factor: 10.121

Review 3.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

4.  Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.

Authors:  Abhijat Kitchlu; Eric McArthur; Eitan Amir; Christopher M Booth; Rinku Sutradhar; Habeeb Majeed; Danielle M Nash; Samuel A Silver; Amit X Garg; Christopher T Chan; S Joseph Kim; Ron Wald
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

5.  Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Ian A Strohbehn; Meghan Lee; Donald F Chute; Halla Bates; Gabriel E Molina; Leyre Zubiri; Shruti Gupta; Shveta Motwani; David E Leaf; Ryan J Sullivan; Osama Rahma; Kimberly G Blumenthal; Alexandra-Chloe Villani; Kerry L Reynolds; Meghan E Sise
Journal:  Kidney Int Rep       Date:  2020-07-21

6.  The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Donald F Chute; Leyre Zubiri; Yaa Oppong; Ian Strohbehn; Frank B Cortazar; David E Leaf; Meghan J Mooradian; Alexandra-Chloé Villani; Ryan J Sullivan; Kerry Reynolds; Meghan E Sise
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-31       Impact factor: 8.237

7.  Rapid kidney function decline and mortality risk in older adults.

Authors:  Dena E Rifkin; Michael G Shlipak; Ronit Katz; Linda F Fried; David Siscovick; Michel Chonchol; Anne B Newman; Mark J Sarnak
Journal:  Arch Intern Med       Date:  2008-11-10

8.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121

9.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Authors:  Josef Coresh; Tanvir Chowdhury Turin; Ron T Gansevoort; Andrew S Levey; Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Lawrence J Appel; Hisatomi Arima; Steven J Chadban; Massimo Cirillo; Ognjenka Djurdjev; Jamie A Green; Gunnar H Heine; Lesley A Inker; Fujiko Irie; Areef Ishani; Joachim H Ix; Csaba P Kovesdy; Angharad Marks; Takayoshi Ohkubo; Varda Shalev; Anoop Shankar; Chi Pang Wen; Paul E de Jong; Kunitoshi Iseki; Benedicte Stengel
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272

10.  Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs.

Authors:  Alyson Haslam; Jennifer Gill; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2020-03-02
  10 in total
  4 in total

Review 1.  Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.

Authors:  Ben Sprangers; David E Leaf; Camillo Porta; Maria José Soler; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2022-09-27       Impact factor: 42.439

2.  Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario.

Authors:  Francesco Trevisani; Federico Di Marco; Matteo Floris; Antonello Pani; Roberto Minnei; Mario Scartozzi; Alessio Cirillo; Alain Gelibter; Andrea Botticelli; Erika Rijavec; Monica Cattaneo; Ornella Garrone; Michele Ghidini
Journal:  Vaccines (Basel)       Date:  2022-04-24

Review 3.  Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms.

Authors:  Mengsi Hu; Qianhui Wang; Bing Liu; Qiqi Ma; Tingwei Zhang; Tongtong Huang; Zhimei Lv; Rong Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-18

Review 4.  Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.

Authors:  Harish Seethapathy; Sandra M Herrmann; Meghan E Sise
Journal:  Kidney Med       Date:  2021-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.